Patents by Inventor Guenter FINGERLE-ROWSON

Guenter FINGERLE-ROWSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230014026
    Abstract: The present disclosure is directed to a combination therapy comprising an antibody or antibody fragment specific for CD19 and a polypeptide that blocks the SIRP?-CD47 innate immune checkpoint for use in the treatment of cancer, in particular hematological cancer such as leukemia or lymphoma.
    Type: Application
    Filed: June 22, 2021
    Publication date: January 19, 2023
    Inventors: Jan ENDELL, Günter FINGERLE-ROWSON, Mark Ping CHAO
  • Publication number: 20220242952
    Abstract: The present disclosure provides characteristics and biomarkers in patients that benefit from treatment with anti-CD19 antibodies (MOR00208, XmAb5574).
    Type: Application
    Filed: May 4, 2020
    Publication date: August 4, 2022
    Inventors: Christian KUFFER, Guenter FINGERLE-ROWSON, Mark WINDERLICH, Jan ENDELL
  • Publication number: 20220184208
    Abstract: The present disclosure is directed to a therapeutic combination of an anti-CD19 antibody and R-CHOP or an anti-CD19 antibody, lenalidomide, and R-CHOP for use in the treatment of diffuse large B cell lymphoma. The present disclosure is also directed to a therapeutic combination of an anti-CD19 antibody, lenalidomide, and rituximab for use in the treatment of non-Hodgkin lymphoma, chronic lymphocytic leukemia, or acute lymphoblastic leukemia.
    Type: Application
    Filed: December 3, 2021
    Publication date: June 16, 2022
    Inventors: Günter FINGERLE-ROWSON, Wolfram BRUGGER, Oliver MANZKE, Francis SEGUY